Antihuman Leukocyte Antigen Antibody-induced Autoimmunity: Role in Chronic Rejection

Overview

Journal Curr Opin Organ Transplant

Specialty General Surgery

Date 2009 Nov 10

PMID 19898237

Citations 27

Authors

Dilip S Nath

Haseeb Illias Basha

Thalachallour Mohanakumar

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: We provide evidence for the role of de-novo development of immune responses to self-antigens in the posttransplant period and its possible induction by alloimmunity in the pathogenesis of chronic rejection following lung, heart and kidney transplantation. The present review details recent findings for the two distinct yet interdependent immune processes in the immunopathogenesis of chronic rejection.

Recent Findings: The contribution of both humoral and cell-mediated alloimmune responses against mismatched donor histocompatibility antigens (HLA) in the pathogenesis of chronic rejection is well established. Recent studies have focused on development of immune responses to self-antigens during the posttransplant period and its correlation with chronic rejection. These self-antigens include myosin and vimentin in cardiac, K-alpha-1-tubulin and collagen-V in lung and angiotensin II type 1 receptor, collagen-IV and VI in kidney transplants. During the posttransplant period, the development of immune responses to self-antigens is facilitated by induction of a distinct subset of autoreactive T-helper cells referred to as Th17 cells.

Summary: Following organ transplantation, tissue injury and remodeling inflicted by antibodies (Abs) to HLA antigens is conducive to develop autoimmunity. Abs to HLA and self-antigens are detectable in the serum of transplant recipients who develop chronic rejection. Anti-HLA Abs are often present transiently but precede the development of Abs to self-antigens.

Citing Articles

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy.

Lin Y, Tsai C, Huang C, Tsai Y, Shih C, Lin S Biomedicines. 2022; 10(5).

PMID: 35625826 PMC: 9139124. DOI: 10.3390/biomedicines10051089.

An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.

Wang J, Zhang W, Roehrl V, Roehrl M, Roehrl M Front Immunol. 2022; 13:831849.

PMID: 35401574 PMC: 8987778. DOI: 10.3389/fimmu.2022.831849.

A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Wang J, Roehrl M, Roehrl V, Roehrl M bioRxiv. 2021; .

PMID: 34373855 PMC: 8351778. DOI: 10.1101/2021.07.30.454526.

Transferring Plasmon Effect on a Biological System: Expression of Biological Polymers in Chronic Rejection and Inflammatory Rat Model.

Tsai C, Lin F, Liu Y, Lin Y, Tsai Y, Huang C Polymers (Basel). 2021; 13(11).

PMID: 34072966 PMC: 8199201. DOI: 10.3390/polym13111827.

Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.

Lin F, Shih C, Huang C, Tsai Y, Loh S, Li C Cardiovasc Drugs Ther. 2020; 35(6):1111-1127.

PMID: 32623597 DOI: 10.1007/s10557-020-07013-w.

References

Atz M, Reed E . Role of anti-MHC class I antibody in facilitating transplant accommodation. Crit Rev Immunol. 2009; 28(6):485-511. DOI: 10.1615/critrevimmunol.v28.i6.20. View

Smyth L, Harker N, Turnbull W, El-Doueik H, Klavinskis L, Kioussis D . The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J Immunol. 2008; 181(5):3212-20. DOI: 10.4049/jimmunol.181.5.3212. View

Smith C, Jaramillo A, Duffy B, Mohanakumar T . Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection. Hum Immunol. 2000; 61(10):985-92. DOI: 10.1016/s0198-8859(00)00175-0. View

Belperio J, Samuel Weigt S, Fishbein M, Lynch 3rd J . Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc. 2009; 6(1):108-21. DOI: 10.1513/pats.200807-073GO. View

Jaramillo A, Smith M, Phelan D, Sundaresan S, Trulock E, Lynch J . Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation. 1999; 67(8):1155-61. DOI: 10.1097/00007890-199904270-00012. View

Goers T, Ramachandran S, Aloush A, Trulock E, Patterson G, Mohanakumar T . De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol. 2008; 180(7):4487-94. PMC: 2796833. DOI: 10.4049/jimmunol.180.7.4487. View

Sato M, Hirayama S, Hwang D, Lara-Guerra H, Wagnetz D, Waddell T . The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation. J Immunol. 2009; 182(11):7307-16. DOI: 10.4049/jimmunol.0803606. View

Lee P, Zhu L, Terasaki P, Everly M . HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation. 2009; 88(4):568-74. DOI: 10.1097/TP.0b013e3181b11b72. View

Yuan X, Paez-Cortez J, Schmitt-Knosalla I, DAddio F, Mfarrej B, Donnarumma M . A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med. 2008; 205(13):3133-44. PMC: 2605226. DOI: 10.1084/jem.20081937. View

10.

Iwata T, Philipovskiy A, Fisher A, Presson Jr R, Chiyo M, Lee J . Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol. 2008; 181(8):5738-47. PMC: 2997998. DOI: 10.4049/jimmunol.181.8.5738. View

11.

Stastny P, Ring S, Lu C, Arenas J, Han M, Lavingia B . Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol. 2009; 70(8):600-4. DOI: 10.1016/j.humimm.2009.04.017. View

12.

Kauke T, Kaczmarek I, Dick A, Schmoeckel M, Deutsch M, Beiras-Fernandez A . Anti-MICA antibodies are related to adverse outcome in heart transplant recipients. J Heart Lung Transplant. 2009; 28(4):305-11. DOI: 10.1016/j.healun.2009.01.003. View

13.

Yang L, Lu Y, Luo G, Song J, Tu Z, Li Y . C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy. Transplant Proc. 2008; 40(8):2786-9. DOI: 10.1016/j.transproceed.2008.08.002. View

14.

Bharat A, Fields R, Steward N, Trulock E, Patterson G, Mohanakumar T . CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant. 2006; 6(8):1799-808. DOI: 10.1111/j.1600-6143.2006.01383.x. View

15.

Illigens B, Yamada A, Anosova N, Dong V, Sayegh M, Benichou G . Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol. 2009; 39(11):3000-9. PMC: 2911804. DOI: 10.1002/eji.200838980. View

16.

Hachem R . Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant. 2009; 14(5):477-82. DOI: 10.1097/MOT.0b013e32832fb981. View

17.

Fotheringham J, Angel C, McKane W . Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract. 2009; 113(1):c1-7. DOI: 10.1159/000228069. View

18.

Burlingham W, Love R, Jankowska-Gan E, Haynes L, Xu Q, Bobadilla J . IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007; 117(11):3498-506. PMC: 2040314. DOI: 10.1172/JCI28031. View

19.

Verleden G, Vos R, De Vleeschauwer S, Willems-Widyastuti A, Verleden S, Dupont L . Obliterative bronchiolitis following lung transplantation: from old to new concepts?. Transpl Int. 2009; 22(8):771-9. DOI: 10.1111/j.1432-2277.2009.00872.x. View

20.

Kuo E, Maruyama T, Fernandez F, Mohanakumar T . Molecular mechanisms of chronic rejection following transplantation. Immunol Res. 2005; 32(1-3):179-85. DOI: 10.1385/IR:32:1-3:179. View